PT  - JOURNAL ARTICLE
AU  - Perez-Saez, Javier
AU  - Zheng, Qulu
AU  - Kaminsky, Joshua
AU  - Zou, Kaiyue
AU  - Demby, Maya N.
AU  - Alam, Christina
AU  - Landau, Daniel
AU  - DePencier, Rachel
AU  - Langa, Jose Paulo M.
AU  - Chilengi, Roma
AU  - Okitayemba, Placide Welo
AU  - Bwire, Godfrey
AU  - Esso, Linda
AU  - Ngomba, Armelle Viviane
AU  - Mbarga, Nicole Fouda
AU  - Okunga, Emmanuel Wandera
AU  - Yennan, Sebastian
AU  - Kapaya, Fred
AU  - Ohize, Stephen Ogirima
AU  - Seriki, Adive Joseph
AU  - Hegde, Sonia T.
AU  - Sikder, Mustafa
AU  - Lessler, Justin
AU  - Datta, Abhirup
AU  - Azman, Andrew S.
AU  - Lee, Elizabeth C.
TI  - A decade of shifting cholera burden in Africa and its implications for control: a statistical mapping analysis
AID  - 10.1101/2024.09.23.24314072
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.09.23.24314072
4099  - http://medrxiv.org/content/early/2024/09/24/2024.09.23.24314072.short
4100  - http://medrxiv.org/content/early/2024/09/24/2024.09.23.24314072.full
AB  - Background The World Health Organization declared a global cholera emergency in 2023 due to an increase in cholera outbreaks, with most cholera-associated deaths reported in Africa. Characterizing large-scale burden patterns can help with monitoring progress in cholera control and targeting interventions.Methods We modeled the mean annual incidence of suspected cholera for 2011-2015 and 2016-2020 on a 20 km by 20 km grid across Africa using a global cholera database and spatial statistical models. We then examined how 2011-2020 incidence is associated with post-2020 cholera occurrence and investigated the potential reach of prospective interventions when prioritized by past incidence.Findings Across 43 African countries mean annual incidence rates remained steady at 11 cases per 100,000 population through both periods. Cholera incidence shifted from Western to Eastern Africa, and we estimated 125,701 cases annually (95% CrI: 124,737-126,717) in 2016-2020. There were 296 million (95% CrI: 282-312 million) people living in high-incidence second-level administrative (ADM2) units (≥ 10 cases per 100,000 per year) in 2020, of which 135 million experienced low incidence (<1 per 100,000) in 2011-2015. ADM2 units with sustained high incidence in Central and Eastern Africa from 2011-2020 were more likely to report cholera in 2022-2023, but cases were also reported in sustained low ADM2 units. Targeting the 100 million highest burden populations had potential to reach up to 63% of 2016-2020 mean annual cases but only 37% when targeting according to past 2011-2015 incidence.Interpretation By revealing the changing spatial epidemiology of cholera in Africa, these 10-year subnational estimates may be used to project OCV demand, characterize the potential of targeting interventions based on past burden, and track progress towards disease control goals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJPS, QZ, JK, KZ, MD, RD, DL, STH, JL, AD, ASA, ECL received funding from the Bill and Melinda Gates Foundation (BMGF INV-044856).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of Johns Hopkins Bloomberg School of Public Health (BSPH) waived ethical approval for this work (BSPH IRB No. 27682).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesPublicly available cholera incidence datasets may be viewed and accessed from cholera-taxonomy.middle-distance.com. Metadata for confidential datasets is available upon request. Data processing and modeling code is publicly available on Github at https://github.com/HopkinsIDD/cholera-mapping-pipeline, release v1.0. https://cholera-taxonomy.middle-distance.com/ https://github.com/HopkinsIDD/cholera-mapping-pipeline/releases/tag/v1.0